401477 Sigma-AldrichIκB Kinase Inhibitor Peptide, Cell-Permeable - Calbiochem
The IκB Kinase Inhibitor Peptide, Cell-Permeable controls the biological activity of IκB Kinase. This small molecule/inhibitor is primarily used for Inflammation/Immunology applications.
More>> The IκB Kinase Inhibitor Peptide, Cell-Permeable controls the biological activity of IκB Kinase. This small molecule/inhibitor is primarily used for Inflammation/Immunology applications. Less<<Synonyms: Ac-AAVALLPAVLLALLAPDDRHDSGLDSMKDE-NH₂
Recommended Products
Overview
Replacement Information |
---|
Key Spec Table
Empirical Formula |
---|
C₁₃₈H₂₂₉N₃₇O₄₅S |
Products
Catalogue Number | Packaging | Qty/Pack | |
---|---|---|---|
401477-1MGCN | 塑膠安瓿;塑膠針藥瓶 | 1 mg |
References | |
---|---|
References | Swaroop, N., et al. 2001. Pharm. Res. 18, 1631. Traenckner, E.B., et al. 1995. EMBO. J. 14, 2876. |
Product Information | |
---|---|
ATP Competitive | N |
Form | Lyophilized |
Formulation | Supplied as a trifluoroacetate salt. |
Hill Formula | C₁₃₈H₂₂₉N₃₇O₄₅S |
Chemical formula | C₁₃₈H₂₂₉N₃₇O₄₅S |
Hygroscopic | Hygroscopic |
Reversible | N |
Quality Level | MQ100 |
Applications |
---|
Physicochemical Information | |
---|---|
Cell permeable | N |
Peptide Sequence | Ac-Ala-Ala-Val-Ala-Leu-Leu-Pro-Ala-Val-Leu-Leu-Ala-Leu-Leu-Ala-Pro-Asp-Asp-Arg-His-Asp-Ser-Gly-Leu-Asp-Ser-Met-Lys-Asp-Glu-NH₂ |
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information |
---|
Product Usage Statements |
---|
Packaging Information | |
---|---|
Packaged under inert gas | Packaged under inert gas |
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Catalogue Number | GTIN |
401477-1MGCN | 04055977211924 |
Documentation
IκB Kinase Inhibitor Peptide, Cell-Permeable - Calbiochem MSDS
Title |
---|
IκB Kinase Inhibitor Peptide, Cell-Permeable - Calbiochem Certificates of Analysis
Title | Lot Number |
---|---|
401477 |
References
Reference overview |
---|
Swaroop, N., et al. 2001. Pharm. Res. 18, 1631. Traenckner, E.B., et al. 1995. EMBO. J. 14, 2876. |